Zdrowie i gospodarka · 15/11/1999

FDA Publishes Semiannual Guidance Agenda for Public Comment

The Food and Drug Administration (FDA) is releasing a semiannual list of potential guidance topics and revisions for public review and comment, as part of its commitment to transparency and public engagement, as outlined in its 1997 Good Guidance Practices policy.